1-[4-[(3,4-Dichlorophenyl)methoxy]phenyl]ethanone, 97%, 5g

2-(2-Chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one hydrochloride, 98%, 1mg

1-[3-(chloromethyl)phenyl]-3,5-dimethyl-1H-pyrazole hydrochloride, 95.0%, 10g

7-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-QUINAZOLINE, 95.0%, 100mg

Benzenesulfonamide, 4-dodecyl-N-1,3,4-thiadiazol-2-yl-, 98%, 100mg

C-Quinolin-3-yl-methylamine dihydrochloride, 95.0%, 5g

N,N-Diphenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline>98.0%(HPLC)(T)1g

ETHYL 2-(4-AMINO-3-NITROPHENYL)ACETATE, 95.0%, 5g

5-Methyl-6-(trifluoromethyl)-1H-indole, 95+%, 250mg

5-chloro-3-{[(2-fluorophenyl)methyl]sulfanyl}-1,2,4-thiadiazole, 95.0%, 1g

Placa calefactora HP-200-S/C series, Vitrocerámica, 500 W, 120 x 120 mm, HP-200-C, 1 Pieza

2,4-Dichloro-5-(trifluoromethoxy)aniline, 95.0%, 1g

tert-Butyl 5-Nitro-1H-indazole-1-carboxylate, 97.0%, 5g